| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DXCM | Common Stock | Other | $0 | -900 | -100% | $0.00* | 0 | May 19, 2022 | Direct | F1 |
| transaction | DXCM | Common Stock | Award | $0.97 | +969 | $0.00* | 969 | May 20, 2022 | Direct | F2, F3 | |
| transaction | DXCM | Common Stock | Other | $0 | +900 | +6.44% | $0.00 | 14.9K | May 19, 2022 | by Partnership | F1, F4 |
| holding | DXCM | Common Stock | 10K | May 20, 2022 | by Spouse | F5 |
| Id | Content |
|---|---|
| F1 | Shares were transferred from direct ownership to ownership under the Skyler Bach Family Limited Partnership, LLP, upon vesting of previously awarded restricted stock units. |
| F2 | The RSU Award was granted on May 20, 2022 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. |
| F3 | Represents 969 restricted stock units which were granted on May 20, 2022 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting. |
| F4 | Shares are held by Skyler Bach Family Limited Partnership, LLP, with respect to which the reporting person is a managing partner of the partnership and maintains voting rights of these shares. |
| F5 | The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. |